NCT02241226

Brief Summary

It is becoming increasingly recognized in the literature that ancient practices for wellbeing, including meditation, yoga, and specific herbs, can improve health and promote longevity. While studies have documented such effects for a variety of individual practices for wellbeing, few studies have taken a more whole systems approach that is simultaneously inclusive of numerous practices. This intervention study, the "Self-Directed Biological Transformation Initiative", will examine the effects of a comprehensive whole systems approach to wellbeing on key biochemical, physiological, and psychosocial endpoints. Participants randomized to the Perfect Health program at the Chopra Center for Wellbeing will be compared to individuals not taking the program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 9, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 16, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

December 16, 2015

Status Verified

December 1, 2015

Enrollment Period

5 months

First QC Date

September 9, 2014

Last Update Submit

December 14, 2015

Conditions

Keywords

wellbeingmeditationAyurvedayogaherbshealthlongevityindividuals

Outcome Measures

Primary Outcomes (4)

  • Change in RNA expression

    Blood samples will be collected for RNA expression and assayed using standardized methodologies

    Assessed pre and post 7 day intervention

  • Change in cytokine levels

    Blood samples will be collected for inflammatory cytokine levels and determined via standardized ELISA methods

    Assessed pre and post 7 day intervention

  • Change in telomerase activity

    Blood samples will be collected for PBMC telomerase activity and assayed using standardized methodologies

    Assessed pre and post 7 day intervention

  • Change in neurohormome levels

    Blood and saliva samples will be collected for neurohormone levels and be determined via standardized ELISA methods

    Assessed pre and post 7 day intervention

Secondary Outcomes (1)

  • Change in heart rate variability

    Assessed pre and post 7 day intervention and one month follow-up

Other Outcomes (4)

  • Change in quality of life

    Assessed pre and post 7 day intervention and one month follow-up

  • Change in gut microbiome populations

    Assessed pre and post 7 day intervention and one month follow-up

  • Change in mood

    Assessed pre and post 7 day intervention and one month follow-up

  • +1 more other outcomes

Study Arms (2)

Perfect health course

EXPERIMENTAL

Perfect health course at the Chopra Center for Wellbeing

Behavioral: Perfect Health Course

Resort group

NO INTERVENTION

Resort group at the La Costa resort

Interventions

The Perfect Health course as taught at the Chopra Center for Wellbeing

Perfect health course

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women between the ages of 40-80 years

You may not qualify if:

  • Self-reported diagnosis of a major medical condition, such as cancer (including those who have received past radiation or chemotherapy treatment), heart disease, autoimmune disease, or diabetes, as these can affect the cell aging system and possibly the ability for telomerase to change in short periods
  • Individuals taking antidepressant medication will be excluded since such medication appears to increase telomerase (Wolkowitz et al, 2010)
  • Individuals with diagnosed PTSD will be excluded; there is evidence that those with PTSD may have lower telomere length as compared to those without PTSD (O'Donovan et al, 2011). It is currently unknown how PTSD may impact telomerase levels
  • Estrogen use is excluded as it increases telomerase (Lin et al, 2011)
  • Smokers will be excluded since smoking decreases telomerase. We will base smoking status on self report. If participants have not smoked regularly for the past 6 months, they will be considered a 'non-smoker
  • Pregnant women are excluded since the cell aging system changes during pregnancy in ways that have not been studied
  • Participants with a Body Mass Index (BMI) of 35 or greater will be excluded due to differences in telomerase activity in obese women
  • Potential eligible participants who are unable to secure the week off from work or other responsibilities will not be enrolled
  • Known atrial fibrillation or other chronic dysrhythmia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chopra Center for Wellbeing

Carlsbad, California, 92009, United States

Location

Study Officials

  • Paul J Mills, PHD

    University of California, San Diego

    STUDY DIRECTOR
  • Rudolph E Tanzi, PhD

    Harvard University

    STUDY CHAIR
  • Deepak Chopra, MD

    Chopra Center for Wellbeing & University of California, San Diego

    STUDY CHAIR
  • Elizabeth Blackburn, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Elissa Epel, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
  • Sheila Patel, MD

    Chopra Center for Wellbeing & University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Valencia Porter, MD

    Chopra Center for Wellbeing & University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Eric Schadt, PhD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR
  • Steven Steinhubl, MD

    Scripps Translational Science Institute, Scripps Research Institute

    PRINCIPAL INVESTIGATOR
  • Eric Topel, MD

    Scripps Translational Science Institute, Scripps Research Institute

    PRINCIPAL INVESTIGATOR
  • Murali Doraiswamy, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 9, 2014

First Posted

September 16, 2014

Study Start

September 1, 2014

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

December 16, 2015

Record last verified: 2015-12

Locations